Pacidamycins are a family of uridyl tetra/pentapeptide antibiotics with antipseudomonal activities through inhibition of the translocase MraY in bacterial cell wall assembly. The biosynthetic gene cluster for pacidamycins has recently been identified through genome mining of the producer Streptomyces coeruleorubidus, and the highly dissociated nonribosomal peptide assembly line for the uridyl tetrapeptide scaffold of pacidamycin has been characterized. In this work a hypothetical protein PacB, conserved in known uridyl peptide antibiotics gene clusters, has been characterized by both genetic deletion and enzymatic analysis of the purified protein. PacB catalyzes the transfer of the alanyl residue from alanyl-tRNA to the N terminus of the tetrapeptide intermediate yielding a pentapeptide on the thio-templated nonribosomal peptide synthetase (NRPS) assembly line protein PacH. PacB thus represents a new group of tRNA-dependent peptide bond-forming enzymes in secondary metabolite biosynthesis in addition to the recently identified cyclodipeptide synthases. The characterization of PacB completes the assembly line reconstitution of pacidamycin pentapeptide antibiotic scaffolds, bridging the primary and secondary metabolic pathways by hijacking an aminoacyl-tRNA to the antibiotic biosynthetic pathway.aminoacyltransferase | uridyl pentapeptide | peptidyl carrier protein P acidamycins are a family of uridyl tetra/pentapeptide antibiotics produced by Streptomyces coeruleorubidus (1). More than 10 related family members have been reported (1, 2): Their common scaffold contains a central N β -methyl 2S,3S-diaminoburytic acid (DABA) moiety which is Îą-amino-capped by a ureido dipeptide (C-terminal), β-amino-capped by a single amino acid or a dipeptide (N-terminal), and carboxy-linked to a 3â˛-deoxy-4â˛,5â˛-enaminouridine ( Fig. 1). Pacidamycins were reported to exert antibiotic activities by virtue of functioning as a substrate analog of the UDP-MurNAc-pentapeptide of MraY in bacterial cell wall assembly of the pentapeptidyl-bactoprenol intermediate (3,4). Pacidamycins are of interest due to their unusual peptidyl-nucleoside structure features, and for the development of next generation antibacterial drugs inhibiting the clinically underexplored cell wall enzyme target MraY. The biosynthetic gene clusters for pacidamycins and closely related napsamycins were identified in parallel recently by three research groups via genome mining (5-7). Bioinformatic analysis revealed the building blocks in pacidamycins are assembled using a nonribosomal peptide synthetase (NRPS) thiotemplate logic, whereas the encoded NRPS modules and domains are highly dissociated and predicted to work with each other in trans. We further characterized the functions of the separate NRPS protein domains in vitro to delineate catalytic steps for activation and insertion of each building block in the pacidamycin scaffold (8, 9). We have shown that nine NRPS enzymes encoded by the producing organism S. coeruleorubidus, when heterologously expressed and purified ...